Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study.Stroke. 2013; 44: 3103-3108
- Increasing prevalence of atrial fibrillation and flutter in the United States.Am J Cardiol. 2009; 104: 1534-1539
- Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.JAMA. 2001; 285: 2370-2375
- Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.Am J Cardiol. 1998; 82: 2N-9N
- Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.Circulation. 2006; 114: 119-125
- Atrial fibrillation complicating lung cancer resection.J Thorac Cardiovasc Surg. 2005; 130: 438-444
- Supraventricular arrhythmias after resection surgery of the lung.Eur J Cardiothorac Surg. 2001; 20: 688-693
- Atrial fibrillation after cardiac surgery: incidence, risk factors, and economic burden.J Cardiothorac Vasc Anesth. 2010; 24: 952-958
- Comparative effectiveness of pharmacotherapies for prevention of atrial fibrillation following coronary artery bypass surgery.Am J Cardiol. 2013; 112: 954-960
- Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT-IV) Trial.Am Heart J. 2009; 158: 792-798
- Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients.J Thorac Cardiovasc Surg. 2004; 127: 779-786
- Prediction rule for atrial fibrillation after major noncardiac thoracic surgery.Ann Thorac Surg. 2005; 79: 1698-1703
- Risk factors for atrial fibrillation after lung cancer surgery: analysis of the Society of Thoracic Surgeons general thoracic surgery database.Ann Thorac Surg. 2010; 90: 368-374
- Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias.Ann Thorac Surg. 1996; 61: 977-982
- Atrial fibrillation after surgery of the lung: clinical analysis of risk factors.Eur J Cardiothorac Surg. 1998; 13: 625-628
- Effect of race on the frequency of postoperative atrial fibrillation following coronary artery bypass grafting.Am J Cardiol. 2011; 107: 383-386
- Comparison of frequency of atrial fibrillation after coronary artery bypass grafting in African Americans versus European Americans.Am J Cardiol. 2011; 108: 669-672
- Influence of race on atrial fibrillation after cardiac surgery.Circ Arrhythm Electrophysiol. 2011; 4: 644-652
- Minimally invasive and conventional aortic valve replacement: a propensity score analysis.Ann Thorac Surg. 2013; 96: 837-843
- Diastolic dysfunction in patients undergoing cardiac surgery: a pathophysiological mechanism underlying the initiation of new-onset post-operative atrial fibrillation.J Am Coll Cardiol. 2011; 58: 953-961
- Prediction of postoperative atrial fibrillation in a large coronary artery bypass grafting cohort.Interact Cardiovasc Thorac Surg. 2012; 14: 588-593
- Predictors and impact of postoperative atrial fibrillation on patients' outcomes: a report from the randomized on versus off bypass trial.J Thorac Cardiovasc Surg. 2012; 143: 93-102
- Postoperative atrial fibrillation is associated with late mortality after coronary surgery, but not after valvular surgery.Ann Thorac Surg. 2009; 88: 1871-1876
- Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients).Am J Cardiol. 2012; 109: 219-225
- Postoperative atrial fibrillation after isolated aortic valve replacement: a cause for concern?.Ann Thorac Surg. 2013; 95: 133-140
- Postoperative atrial fibrillation in noncardiothoracic surgical patients.Am J Surg. 2001; 182: 713-715
- Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery.Am Heart J. 2012; 164: 918-924
- Supraventricular arrhythmia in patients having noncardiac surgery: clinical correlates and effect on length of stay.Ann Intern Med. 1998; 129: 279-285
- Minimally invasive aortic valve replacement using right minithoracotomy is associated with better outcomes than ministernotomy.J Thorac Cardiovasc Surg. 2014; 148: 133-137https://doi.org/10.1016/j.jtcvs.2013.07.060
- Incidence of postoperative atrial in patients undergoing minimally invasive versus median sternotomy valve surgery.J Thorac Cardiovasc Surg. 2013; 146: 1436-1441
- Transcatheter versus surgical aortic-valve replacement in high-risk patients.N Engl J Med. 2011; 364: 2187-2198
- Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke prevention in Atrial Fibrillation Investigators.J Am Coll Cardiol. 2000; 35: 183-187
- Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.J Am Coll Cardiol. 2007; 50: 2156-2161
- Stroke in paroxysmal atrial fibrillation: report from the stockholm cohort of atrial fibrillation.Eur Heart J. 2010; 31: 967-975
- Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?.Eur Heart J. 2008; 29: 915-922
- New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft.J Am Coll Cardiol. 2010; 55: 1370-1376
- New onset postoperative atrial fibrillation is associated with a long-term risk for stroke and death following cardiac surgery.J Card Surg. 2013; 28: 8-13
- The impact of new-onset postoperative atrial fibrillation on mortality after coronary artery bypass grafting.Ann Thorac Surg. 2010; 90: 443-449
- Postoperative atrial fibrillation and mortality after coronary artery bypass surgery.J Am Coll Cardiol. 2004; 43: 742-748
- The impact of race and postoperative atrial fibrillation on operative mortality after elective coronary artery bypass grafting.Eur J Cardiothorac Surg. 2014; 45: e20-e25
- Postoperative atrial fibrillation is a major cause of stroke after on-pump coronary artery bypass surgery.Ann Thorac Surg. 2004; 77: 1241-1244
- Intra- and postoperative predictors of stroke after coronary artery bypass grafting.Ann Thorac Surg. 2003; 76: 428-434
- Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality.Eur J Cardiothorac Surg. 2010; 37: 1353-1359
- Incidence of postdischarge symptomatic paroxysmal atrial fibrillation in patients who underwent coronary artery bypass graft: long-term follow-up.Pacing Clin Electrophysiol. 2004; 27: 365-367
- Late postoperative atrial fibrillation after cardiac surgery: a national survey within the cardiac rehabilitation setting.J Cardiovasc Med. 2011; 12: 390-395
- Early and delayed stroke after coronary surgery - an analysis of risk factors and the impact on short- and long-term survival.Eur J Cardiothorac Surg. 2011; 40: 379-387
- New-onset postoperative atrial fibrillation and long-term survival after aortic valve replacement surgery.Ann Thorac Surg. 2010; 90: 474-479
- Prevention of post-coronary artery bypass grafting (CABG) atrial fibrillation: efficacy of prophylactic beta-blockers in the modern era: a meta-analysis of latest randomized controlled trials.Ann Noninvasive Electrocardiol. 2013; 18: 58-68
- 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.Circulation. 2011; 123: e269-e367
- Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: a network regression meta-analysis.Pacing Clin Electrophysiol. 2013; 36: 1017-1023
- Meta-analysis of amiodarone versus β-blocker as a prophylactic therapy against atrial fibrillation following cardiac surgery.Intern Med J. 2012; 42: 1078-1087
- Amiodarone significantly decreases atrial fibrillation in patients undergoing surgery for lung cancer.Ann Thorac Surg. 2012; 94: 339-344
- A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection.Ann Thorac Surg. 2009; 88 ([discussion: 894–5]): 886-893
- Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis.J Thorac Cardiovasc Surg. 2010; 140: 364-372
- Preoperative statin therapy for patients undergoing cardiac surgery.Cochrane Database Syst Rev. 2012; (CD008493)
- Systemic magnesium to reduce postoperative arrhythmias after coronary artery bypass graft surgery: a meta-analysis of randomized controlled trials.J Cardiothorac Vasc Anesth. 2012; 26: 643-650
- Prophylactic magnesium does not prevent atrial fibrillation after cardiac surgery: a meta-analysis.Ann Thorac Surg. 2013; 95: 533-541
- N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials.J Am Heart Assoc. 2013; 2: e005033
- Prevention of postoperative atrial fibrillation in open heart surgery patients by preoperative supplementation of n-3 polyunsaturated fatty acids: an updated meta-analysis.J Thorac Cardiovasc Surg. 2013; 146: 906-911
- Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting.Am J Cardiol. 2012; 110: 919-923
- Preoperative treatment with an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker has no beneficial effect on the development of new-onset atrial fibrillation after off-pump coronary artery bypass graft surgery.Clin Cardiol. 2012; 35: 37-42
- A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.N Engl J Med. 2002; 347: 1834-1840
- A comparison of rate control and rhythm control in patients with atrial fibrillation.N Engl J Med. 2002; 347: 1825-1833
- Rhythm or rate control in atrial fibrillation–Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial.Lancet. 2000; 356: 1789-1794
- Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) Study.J Am Coll Cardiol. 2003; 41: 1690-1696
- Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study.Kardiol Pol. 2003; 59: 1-16
- Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.Am Heart J. 2000; 140: 871-877
- Clinical outcome of patients who develop PAF after CABG surgery.Pacing Clin Electrophysiol. 2001; 24: 191-193
- The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study: approaches to control rate in atrial fibrillation.J Am Coll Cardiol. 2004; 43: 1201-1208
- Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: a randomized controlled study.Cardiovasc Drugs Ther. 2003; 17: 31-39
- Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.J Am Coll Cardiol. 1996; 28: 700-706
- Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.N Engl J Med. 1999; 340: 1849-1854
- Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter.J Am Coll Cardiol. 1992; 19: 851-855
- Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).Eur Heart J. 2010; 31: 2369-2429
- Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.JAMA. 2001; 285: 2864-2870
- Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation.Chest. 2010; 137: 263-272
- Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.BMJ. 2011; 342: d124
- A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.Chest. 2010; 138: 1093-1100
- Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.J Am Coll Cardiol. 2011; 57: 173-180
- A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.J Am Coll Cardiol. 2011; 58: 395-401
- Classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).Am Heart J. 2006; 151: 713-719
- Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study.Lancet. 1989; 1: 175-179
- Stroke prevention in Atrial Fibrillation Study. Final results.Circulation. 1991; 84: 527-539
- Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group.Lancet. 1993; 342: 1255-1262
- European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.J Neurol Sci. 1996; 143: 1-13
- Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group.Am Heart J. 1999; 138: 137-143
- Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial.Stroke. 2006; 37: 447-451
- Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.Ann Intern Med. 2007; 146: 857-867
- The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.N Engl J Med. 1990; 323: 1505-1511
- Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.J Am Coll Cardiol. 1991; 18: 349-355
- Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.N Engl J Med. 1992; 327: 1406-1412
- Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?.JAMA. 2003; 290: 2685-2692
- Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.Lancet. 1994; 343: 687-691
- Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study.Arch Intern Med. 1998; 158: 1513-1521
- The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin.Zhonghua Xin Xue Guan Bing Za Zhi. 2006; 34 ([in Chinese]): 295-298
- Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.Lancet. 2007; 370: 493-503
- Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.Lancet. 2006; 367: 1903-1912
- Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.Lancet. 2013; 381: 1107-1115
- Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.J Am Coll Cardiol. 2013; 62: 981-989
- Dabigatran versus warfarin in patients with atrial fibrillation.N Engl J Med. 2009; 361: 1139-1151
- Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.N Engl J Med. 2011; 365: 883-891
- Apixaban versus warfarin in patients with atrial fibrillation.N Engl J Med. 2011; 365: 981-992
- Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor.Clin Appl Thromb Hemost. 2009; 15: 9S-16S
- Apixaban metabolism and pharmacokinetics after oral administration to humans.Drug Metab Dispos. 2009; 37: 74-81
- Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939–an oral, direct Factor Xa inhibitor–after multiple dosing in healthy male subjects.Eur J Clin Pharmacol. 2005; 61: 873-880
- Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects.Curr Med Res Opin. 2008; 24: 2757-2765
- Apixaban in patients with atrial fibrillation.N Engl J Med. 2011; 364: 806-817
- Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.Circulation. 2012; 126: 343-348
- Dabigatran versus warfarin in patients with mechanical heart valves.N Engl J Med. 2013; 369: 1206-1214
- Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers.Thromb Haemost. 2012; 108: 217-224
- Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.Circulation. 2011; 124: 1573-1579
- Reversal of apixaban induced alterations in hemostasis by different coagulation factor concentrates: significance of studies in vitro with circulating human blood.PLoS One. 2013; 8: e78696
- Measurement and reversal of prophylactic and therapeutic peak levels of rivaroxaban: an In Vitro Study.Clin Appl Thromb Hemost. 2013; https://doi.org/10.1177/1076029613494468
- Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding.Blood. 2012; 119: 2172-2174
- A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa.Nat Med. 2013; 19: 446-451
- Routine anticoagulation is not indicated for postoperative general thoracic surgical patients with new-onset atrial fibrillation.Ann Thorac Surg. 2011; 92: 421-426
- Relationship of atrial fibrillation and stroke after coronary artery bypass graft surgery: when is anticoagulation indicated?.Ann Thorac Surg. 2006; 82: 515-523
- Does warfarin help prevent ischemic stroke in patients presenting with post coronary bypass paroxysmal atrial fibrillation?.Ann Thorac Cardiovasc Surg. 2013; 19: 207-211
- Anticoagulation: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery.Chest. 2005; 128: 24S-27S
- Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest. 2012; 141: e531S-e575S
Article info
Publication history
Published online: July 19, 2014
Footnotes
Conflict of Interest Statements: None (E. Anderson, MD); Consultant: The Medicines Company, Grifols S.A; Speaker’s Bureau: Pfizer, Bristol-Myers Squibb (C. Dyke, MD); Prof. J.H. Levy serves on steering committees for Boehringer Ingelheim, CSL Behring AG, Grifols, Janssen Pharmaceuticals, and The Medicines Company.
Identification
Copyright
© 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
